Should the duration of oral suppressive antimicrobial therapy diff er by pathogen (e.g., methicillin-sensitive Staphylococcus aureus (MSSA) vs. methicillin-resistant S. aureus (MRSA)) in the treatment of subacute or chronic shoulder periprosthetic joint infection (PJI)?

Authors: Henk Scheper, Jeremy Somerson, William Levine, Jose L. Del Pozo, Brian Grogan
RECOMMENDATION: There is insuffi cient evidence to determine whether the duration of oral suppressive antimicrobial therapy should differ by pathogen in the treatment of subacute/chronic shoulder PJI.
LEVEL OF EVIDENCE: Limited
DELEGATE VOTE: Agree: 100%, Disagree: 0%, Abstain: 0% (Unanimous, Strongest Consensus)